Histone deacetylase inhibitor sodium butyrate regulates the activation of toll-like receptor 4/interferon regulatory factor-3 signaling pathways in prostate cancer cells.
Saved in:
| Title: | Histone deacetylase inhibitor sodium butyrate regulates the activation of toll-like receptor 4/interferon regulatory factor-3 signaling pathways in prostate cancer cells. |
|---|---|
| Authors: | Ozkan, Asuman1 (AUTHOR), Eskiler, Gamze1 (AUTHOR), Kazan, Nur2 (AUTHOR), Turna, Ozge3 (AUTHOR) |
| Source: | Journal of Cancer Research & Therapeutics. Oct-Dec2023, Vol. 19 Issue 7, p1812-1817. 6p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
